Maris JM - Search Results

1

Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models.

Morowitz MJ, Barr R, Wang Q, King R, Rhodin N, Pawel B, Zhao H, Erickson SA, Sheppard GS, Wang J, Maris JM, Shusterman S. Morowitz MJ, et al. Among authors: maris jm. Clin Cancer Res. 2005 Apr 1;11(7):2680-5. doi: 10.1158/1078-0432.CCR-04-1917. Clin Cancer Res. 2005. PMID: 15814649

2

Significance of chromosome 1p loss of heterozygosity in neuroblastoma.

Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Maris JM, et al. Cancer Res. 1995 Oct 15;55(20):4664-9. Cancer Res. 1995. PMID: 7553646

3

No CDKN2 mutations in neuroblastomas.

Beltinger CP, White PS, Sulman EP, Maris JM, Brodeur GM. Beltinger CP, et al. Among authors: maris jm. Cancer Res. 1995 May 15;55(10):2053-5. Cancer Res. 1995. PMID: 7743501

4

Familial predisposition to neuroblastoma does not map to chromosome band 1p36.

Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Yanofsky RA, Feldman GL, Brodeur GM. Maris JM, et al. Cancer Res. 1996 Aug 1;56(15):3421-5. Cancer Res. 1996. PMID: 8758905

5

Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.

Sulman EP, Dumanski JP, White PS, Zhao H, Maris JM, Mathiesen T, Bruder C, Cnaan A, Brodeur GM. Sulman EP, et al. Among authors: maris jm. Cancer Res. 1998 Aug 1;58(15):3226-30. Cancer Res. 1998. PMID: 9699646

6

Molecular biology of neuroblastoma.

Maris JM, Matthay KK. Maris JM, et al. J Clin Oncol. 1999 Jul;17(7):2264-79. doi: 10.1200/JCO.1999.17.7.2264. J Clin Oncol. 1999. PMID: 10561284 Review.

7

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM. Maris JM, et al. J Clin Oncol. 2000 May;18(9):1888-99. doi: 10.1200/JCO.2000.18.9.1888. J Clin Oncol. 2000. PMID: 10784629

8

Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.

Weiss MJ, Guo C, Shusterman S, Hii G, Mirensky TL, White PS, Hogarty MD, Rebbeck TR, Teare D, Urbanek M, Brodeur GM, Maris JM. Weiss MJ, et al. Among authors: maris jm. Med Pediatr Oncol. 2000 Dec;35(6):526-30. doi: 10.1002/1096-911x(20001201)35:6<526::aid-mpo5>3.0.co;2-s. Med Pediatr Oncol. 2000. PMID: 11107108

9

Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.

Shusterman S, Grupp SA, Maris JM. Shusterman S, et al. Among authors: maris jm. Med Pediatr Oncol. 2000 Dec;35(6):673-6. doi: 10.1002/1096-911x(20001201)35:6<673::aid-mpo41>3.0.co;2-o. Med Pediatr Oncol. 2000. PMID: 11107144

10

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS. Thompson PM, et al. Among authors: maris jm. Cancer Res. 2001 Jan 15;61(2):679-86. Cancer Res. 2001. PMID: 11212268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters